D-Dimer plasma concentration in various clinical conditions: Implication for the use of this test in the diagnostic approach of venous thromboembolism
- 1 January 1993
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 69 (1) , 125-130
- https://doi.org/10.1016/0049-3848(93)90009-d
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Effects of exercise test on plasma markers of an activation of coagulation and/or fibrinolysis in patients with symptomatic or silent myocardial ischemiaThrombosis Research, 1992
- Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolismThe Lancet, 1991
- Plasma cross linked fibrin degradation products in pulmonary embolism.Thorax, 1990
- Monoclonal antibody-based plasma assays for fibrin(ogen) and derivatives, and their clinical relevanceBlood Coagulation & Fibrinolysis, 1990
- Measurement of Plasma D-Dimer for Diagnosis of Deep Venous ThrombosisAmerican Journal of Clinical Pathology, 1989
- Plasma D‐dimer levels and their relationship to serum fibrinogen/fibrin degradation products in hypercoagulable statesBritish Journal of Haematology, 1989
- Utility of cross-linked fibrin degradation products in the diagnosis of pulmonary embolismAmerican Heart Journal, 1988
- Assessment of D‐dimer in Plasma: Diagnostic Value in Suspected Deep Venous Thrombosis of the LegActa Medica Scandinavica, 1988
- Plasma assays for derivatives of fibrin and of fibrinogen, based on monoclonal antibodiesFibrinolysis, 1988
- Increased plasma concentration of cross-linked fibrin polymers in acute myocardial infarction.Circulation, 1987